In prostate cancer, EZH2 ablation also triggers an endogenous double-stranded RNA-STING axis-induced interferon response that enhances ICB therapy by increasing antigen presentation, Th1 chemokine signaling, and tumor infiltrations of activated CD8+ T cells and M1 tumor-associated macrophages [168]. This evidence concerns the gene STING1 and neoplasm.